Should I use PT-141 as an injection or nasal spray?
PT-141 (bremelanotide) is sold under the brand Vyleesi as a 1.75 mg subcutaneous autoinjector for women with low sexual desire. Compounded versions come as both injections and nasal sprays. Injections give a more predictable onset (about 45 minutes) and longer effect window (6-12 hours) but more nausea. Nasal sprays kick in faster (20-60 minutes) and wear off faster (up to 4 hours), which some people prefer for spontaneity. There is no head-to-head trial; pick based on whether you want predictability or convenience.
- Vyleesi (the approved-in-the-US version) is injection-only at 1.75 mg per dose
- Compounded nasal sprays typically run 1-10 mg/mL; common starting dose is 1-2 sprays per nostril
- Injection onset ~45 min, duration 6-12 hours; nasal onset 20-60 min, duration up to 4 hours
- Nasal absorption bypasses first-pass metabolism but is more variable person to person
- Both forms work on the same melanocortin pathway in the brain - the difference is delivery, not mechanism
Your guided peptide companion.
PRTCL walks beginners through their first peptide with confidence - guided reconstitution, dose calculation, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.
- · Guided walkthrough for your first dose
- · Dose calculator that does the math for you
- · Vial inventory and dose log tracking
- · Library of physician-vetted protocols
Free to start. Sign in if you already have an account.